T reg cells—the next frontier of cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

T reg cells—the next frontier of cell therapy

Published:2018-10-12 Issue:6411 Volume:362 Page:154-155
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Bluestone Jeffrey A.¹²,Tang Qizhi³

Affiliation:

1. Diabetes Center, University of California, San Francisco, CA 94143, USA.

2. Sean N. Parker Autoimmune Research Laboratory, University of California, San Francisco, CA 94143, USA.

3. Department of Surgery, University of California, San Francisco, CA 94143, USA.

Abstract

Will regulatory T cells be a frontline therapy for autoimmunity and other diseases?

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference15 articles.

1. Chimeric Antigen Receptor Therapy

2. The global landscape of cancer cell therapy

3. Inducing and Administering Tregs to Treat Human Disease

4. Regulatory T Cells and Immune Tolerance

5. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxynitrite reduces Treg cell expansion and function by mediating IL-2R nitration and aggravates multiple sclerosis pathogenesis;Redox Biology;2024-09

2. IL-27/Blimp-1 axis regulates the differentiation and function of Tim-3⁺ Tregs during early pregnancy;JCI INSIGHT;2024

3. CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets;Frontiers in Immunology;2024-06-28

4. Phase and Defect Engineering of MoSe₂ Nanosheets for Enhanced NIR-II Photothermal Immunotherapy;Nano Letters;2024-06-12

5. Blockade of CD80/CD86-CD28 co-stimulation augments the inhibitory function of peptide antigen-specific regulatory T cells;Biomedical Research;2024-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3